These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6998553)

  • 21. Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage III lung cancer.
    Bjornsson S; Takita H; Kuberka N; Preisler H; Catane H; Higby D; Henderson E
    Cancer Treat Rep; 1978 Apr; 62(4):505-10. PubMed ID: 350388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous Corynebacterium parvum: an adjunct to chemotherapy for resistant advanced ovarian cancer.
    Rao B; Wanebo HJ; Ochoa M; Lewis JL; Oettgen HF
    Cancer; 1977 Feb; 39(2):514-26. PubMed ID: 837334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced ovarian carcinoma: a prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF).
    Carmo-Pereira J; Costa FO; Henriques E; Ricardo JA
    Cancer; 1981 Nov; 48(9):1947-51. PubMed ID: 6271386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinoma.
    Omura GA; Morrow CP; Blessing JA; Miller A; Buchsbaum HJ; Homesley HD; Leone L
    Cancer; 1983 Mar; 51(5):783-9. PubMed ID: 6401594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
    Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer.
    Bruckner HW; Dinse GE; Davis TE; Falkson G; Creech RH; Arseneau JC; Greenspan EM; Brodovsky HS; Pagano M; Hahn RG
    Cancer; 1985 Jan; 55(1):26-40. PubMed ID: 3917352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Requirements for successful immunotherapy and chemoimmunotherapy of a murine model of ovarian cancer.
    Vanhaelen CP; Fisher RI
    Cancer Res; 1981 Mar; 41(3):980-3. PubMed ID: 7193085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.
    Bruckner HW; Pagano M; Falkson G; Creech R; Arseneau JC; Horton J; Brodovsky H; Davis TE; Slayton RW; Greenspan E
    Cancer Treat Rep; 1979 Feb; 63(2):297-9. PubMed ID: 376136
    [No Abstract]   [Full Text] [Related]  

  • 30. Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer.
    Thatcher N; Honeybourne D; Wagstaff J; Carroll KB; Barber PV; Morrison JB; Crowther D
    Br J Dis Chest; 1984 Jan; 78(1):89-97. PubMed ID: 6318791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of Corynebacterium parvum in combination with 5-fluorouracil, L-phenylalanine mustard, or methotrexate on the inhibition of tumor growth.
    Fisher B; Rubin H; Saffer E; Wolmark N
    Cancer Res; 1976 Aug; 36(8):2714-9. PubMed ID: 1277181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites.
    Cadman E; Farber L; Berd D; Bertino J
    Cancer Treat Rep; 1977 Sep; 61(6):1109-16. PubMed ID: 332346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
    Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoimmunotherapy with Corynebacterium parvum in acute myelocytic leukemia.
    Eppinger-Helft M; Pavlovsky S; Hidalgo G; Muriel FS; Suárez A; Garay G; Russo C; Santos M; Macchi A; Lein J
    Cancer; 1980 Jan; 45(2):280-4. PubMed ID: 6985835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose methotrexate with cyclophosphamide and cis-platinum in treatment of advanced ovarian carcinoma.
    Lele SB; Piver MS; Barlow JJ
    Gynecol Oncol; 1979 Aug; 8(1):74-7. PubMed ID: 313358
    [No Abstract]   [Full Text] [Related]  

  • 37. Methotrexate-citrovorum factor used alone and in combination chemotherapy for advanced hypernephromas.
    Baumgartner G; Heinz R; Arbes H; Lenzhofer R; Pridun N; Schüller J
    Cancer Treat Rep; 1980 Jan; 64(1):41-6. PubMed ID: 6155211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
    Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
    Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.
    Woodruff MF; Whitehead VL; Speedy G
    Br J Cancer; 1978 Mar; 37(3):345-55. PubMed ID: 638014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.